Pfizer (PFE) Assets (2009 - 2026)
Pfizer (PFE) posted quarterly Assets of $208.0 billion for Q1 2026, little changed year-over-year from $208.0 billion in Q1 2025, and little changed quarter-over-quarter from $208.0 billion in Q4 2025.
Pfizer (PFE) Assets (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Assets for 18 consecutive years, with $208.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets changed 0.01% year-over-year to $208.0 billion; the TTM figure through Mar 2026 stood at $208.0 billion (changed 0.01% YoY), while the FY2025 annual figure was $208.0 billion, down 2.35% from the prior year.
- Assets steadied at $208.0 billion in Q1 2026 per PFE's latest filing, from $208.0 billion in the prior quarter.
- Across five years, Assets topped out at $227.0 billion in Q4 2023 and bottomed at $41.1 billion in Q3 2022.
- Historically, Assets has averaged $188.9 billion across 5 years, with a median of $208.0 billion in 2025.
- Annual changes were most pronounced in 2022 — Assets fell 11.22% — and 2024, when it surged 412.44%.
- Pfizer's Assets stood at $197.0 billion in 2022, then grew by 15.23% to $227.0 billion in 2023, then dropped by 6.17% to $213.0 billion in 2024, then declined by 2.35% to $208.0 billion in 2025, then changed by 0.0% to $208.0 billion in 2026.
- Business Quant data shows PFE's Assets at $208.0 billion in Q1 2026, $208.0 billion in Q4 2025, and $208.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 82.83 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 150.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 201.13 Bn |
| Mar 29, 2026 | 208.00 Bn |
| Dec 31, 2025 | 208.00 Bn |
| Sep 28, 2025 | 208.73 Bn |
| Jun 29, 2025 | 206.10 Bn |
| Mar 30, 2025 | 208.03 Bn |
| Dec 31, 2024 | 213.00 Bn |
| Sep 29, 2024 | 219.48 Bn |
| Jun 30, 2024 | 216.00 Bn |
| Mar 31, 2024 | 221.10 Bn |
| Dec 31, 2023 | 227.00 Bn |
| Sep 30, 2023 | 42.83 Bn |
| Jul 2, 2023 | 220.17 Bn |
| Apr 2, 2023 | 196.00 Bn |
| Dec 31, 2022 | 197.00 Bn |
| Sep 30, 2022 | 41.14 Bn |
| Jul 3, 2022 | 195.29 Bn |
| Apr 3, 2022 | 183.84 Bn |
| Dec 31, 2021 | 181.00 Bn |
| Oct 3, 2021 | 46.34 Bn |